GCH1 and dystonia 5: Additional therapies may be required in some forms of DRD such as 5-hydroxytryptophan (5-HTP, up to 6 mg/kg/day) in sepiapterin reductase deficiency [25, 26], and 5-HTP and BH4 in autosomal recessive GCH1 mutations [27].